Strategies of extensively drug-resistant TB risk management for health workers and other care givers

Chen Yuan Chiang, Donald A. Enarson, Paula I. Fujiwara, Armand van Deun, Jen J. Lee

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first principle in managing the risk of extensively drug-resistant TB (XDR-TB) is 'do not generate XDR-TB'. Once it is created, every effort must be made to prevent it from spreading. Health workers and care givers in long-term care facilities and prisons may have a considerable risk of exposure to TB, including XDR-TB. The principles in the control of TB transmission in healthcare settings, long-term care facilities and prisons include early identification and isolation of infectious TB patients, effective treatment of TB as soon as possible, environmental control with proper ventilation and personal protection of healthcare workers and others. Patients with the highest risk of developing XDR-TB are those MDR-TB patients who failed treatment using a second-line regimen and TB patients who have a history of contact with XDR-TB patients. The core principles in managing the risk of XDR-TB for health workers and care givers are reducing the risks of exposure to XDR-TB, becoming infected and developing XDR-TB. If TB has developed, the principles include promptly diagnosing XDR-TB and starting proper treatment.

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalExpert Review of Respiratory Medicine
Volume2
Issue number1
DOIs
Publication statusPublished - Feb 2008
Externally publishedYes

Fingerprint

Extensively Drug-Resistant Tuberculosis
Risk Management
Caregivers
Health
Pharmaceutical Preparations
Delivery of Health Care
Prisons
Long-Term Care
Drug Resistance
Ventilation
Therapeutics

Keywords

  • Administrative controls
  • Environmental controls
  • MDR-TB
  • Personal protection
  • Prevention
  • Rapid susceptibility testing
  • Tuberculosis
  • XDR-TB

ASJC Scopus subject areas

  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health
  • Pulmonary and Respiratory Medicine

Cite this

Strategies of extensively drug-resistant TB risk management for health workers and other care givers. / Chiang, Chen Yuan; Enarson, Donald A.; Fujiwara, Paula I.; van Deun, Armand; Lee, Jen J.

In: Expert Review of Respiratory Medicine, Vol. 2, No. 1, 02.2008, p. 47-54.

Research output: Contribution to journalArticle

Chiang, Chen Yuan ; Enarson, Donald A. ; Fujiwara, Paula I. ; van Deun, Armand ; Lee, Jen J. / Strategies of extensively drug-resistant TB risk management for health workers and other care givers. In: Expert Review of Respiratory Medicine. 2008 ; Vol. 2, No. 1. pp. 47-54.
@article{9b1b70e763d94d6f9bc5481e31587dcf,
title = "Strategies of extensively drug-resistant TB risk management for health workers and other care givers",
abstract = "Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first principle in managing the risk of extensively drug-resistant TB (XDR-TB) is 'do not generate XDR-TB'. Once it is created, every effort must be made to prevent it from spreading. Health workers and care givers in long-term care facilities and prisons may have a considerable risk of exposure to TB, including XDR-TB. The principles in the control of TB transmission in healthcare settings, long-term care facilities and prisons include early identification and isolation of infectious TB patients, effective treatment of TB as soon as possible, environmental control with proper ventilation and personal protection of healthcare workers and others. Patients with the highest risk of developing XDR-TB are those MDR-TB patients who failed treatment using a second-line regimen and TB patients who have a history of contact with XDR-TB patients. The core principles in managing the risk of XDR-TB for health workers and care givers are reducing the risks of exposure to XDR-TB, becoming infected and developing XDR-TB. If TB has developed, the principles include promptly diagnosing XDR-TB and starting proper treatment.",
keywords = "Administrative controls, Environmental controls, MDR-TB, Personal protection, Prevention, Rapid susceptibility testing, Tuberculosis, XDR-TB",
author = "Chiang, {Chen Yuan} and Enarson, {Donald A.} and Fujiwara, {Paula I.} and {van Deun}, Armand and Lee, {Jen J.}",
year = "2008",
month = "2",
doi = "10.1586/17476348.2.1.47",
language = "English",
volume = "2",
pages = "47--54",
journal = "Expert Review of Respiratory Medicine",
issn = "1747-6348",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Strategies of extensively drug-resistant TB risk management for health workers and other care givers

AU - Chiang, Chen Yuan

AU - Enarson, Donald A.

AU - Fujiwara, Paula I.

AU - van Deun, Armand

AU - Lee, Jen J.

PY - 2008/2

Y1 - 2008/2

N2 - Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first principle in managing the risk of extensively drug-resistant TB (XDR-TB) is 'do not generate XDR-TB'. Once it is created, every effort must be made to prevent it from spreading. Health workers and care givers in long-term care facilities and prisons may have a considerable risk of exposure to TB, including XDR-TB. The principles in the control of TB transmission in healthcare settings, long-term care facilities and prisons include early identification and isolation of infectious TB patients, effective treatment of TB as soon as possible, environmental control with proper ventilation and personal protection of healthcare workers and others. Patients with the highest risk of developing XDR-TB are those MDR-TB patients who failed treatment using a second-line regimen and TB patients who have a history of contact with XDR-TB patients. The core principles in managing the risk of XDR-TB for health workers and care givers are reducing the risks of exposure to XDR-TB, becoming infected and developing XDR-TB. If TB has developed, the principles include promptly diagnosing XDR-TB and starting proper treatment.

AB - Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first principle in managing the risk of extensively drug-resistant TB (XDR-TB) is 'do not generate XDR-TB'. Once it is created, every effort must be made to prevent it from spreading. Health workers and care givers in long-term care facilities and prisons may have a considerable risk of exposure to TB, including XDR-TB. The principles in the control of TB transmission in healthcare settings, long-term care facilities and prisons include early identification and isolation of infectious TB patients, effective treatment of TB as soon as possible, environmental control with proper ventilation and personal protection of healthcare workers and others. Patients with the highest risk of developing XDR-TB are those MDR-TB patients who failed treatment using a second-line regimen and TB patients who have a history of contact with XDR-TB patients. The core principles in managing the risk of XDR-TB for health workers and care givers are reducing the risks of exposure to XDR-TB, becoming infected and developing XDR-TB. If TB has developed, the principles include promptly diagnosing XDR-TB and starting proper treatment.

KW - Administrative controls

KW - Environmental controls

KW - MDR-TB

KW - Personal protection

KW - Prevention

KW - Rapid susceptibility testing

KW - Tuberculosis

KW - XDR-TB

UR - http://www.scopus.com/inward/record.url?scp=47649089814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47649089814&partnerID=8YFLogxK

U2 - 10.1586/17476348.2.1.47

DO - 10.1586/17476348.2.1.47

M3 - Article

VL - 2

SP - 47

EP - 54

JO - Expert Review of Respiratory Medicine

JF - Expert Review of Respiratory Medicine

SN - 1747-6348

IS - 1

ER -